Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kai Hermanns"'
Publikováno v:
Expert Opinion on Pharmacotherapy. 16:457-464
Prolonged-release oxycodone/naloxone (OXN PR) showed improved gastrointestinal tolerability and equivalent analgesic efficacy compared to oxycodone alone in patients with non-cancer pain or cancer pain. This is the first dataset to demonstrate its ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da685c5a5e9eff0e45bebeda8a81cc3b
https://doi.org/10.1517/14656566.2015.1001737
https://doi.org/10.1517/14656566.2015.1001737
Autor:
Amy Pierce, John Langan, Kai Hermanns, John I. Wurzelmann, Christi S. Kleoudis, Daniel Lorch, Jerry Snidow, E. Mortensen, Ben Lasko, Jan-Peter Jansen
Publikováno v:
The Journal of Pain. 12:185-193
Gastrointestinal (GI) side effects are common with opioid medication, and constipation affects ∼40% of patients. Such symptoms considerably impair patients' quality of life. Alvimopan is an orally administered, systemically available, peripherally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c62e1dd9995df12127eb33b4db60ab
https://doi.org/10.1016/j.jpain.2010.06.012
https://doi.org/10.1016/j.jpain.2010.06.012
Autor:
Karen Reimer, Petra Leyendecker, Dana Vondrackova, Winfried Meissner, Istvan Szombati, Susanne Weber, Kai Hermanns, Michael Hopp, Birgit Grothe, Christian Ruckes, Wolfgang Fleischer
Publikováno v:
The Journal of Pain. 9:1144-1154
This randomized, double-blind, placebo- and active-controlled, parallel-group study was designed to demonstrate the superiority of oxycodone in combination with naloxone in a prolonged release (PR) formulation over placebo with respect to analgesic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfec22045aa2c93238b4c1c0bb621c70
https://doi.org/10.1016/j.jpain.2008.06.014
https://doi.org/10.1016/j.jpain.2008.06.014
Publikováno v:
Expert opinion on pharmacotherapy. 13(3)
Opioids have shown consistent efficacy in neuropathic pain, but opioid-induced bowel dysfunction is a relevant problem. In controlled clinical trials, a fixed-dose combination of prolonged-release (PR) oxycodone/PR naloxone was superior to oxycodone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2cd3b5ca694ecec5f019b8214583150
https://pubmed.ncbi.nlm.nih.gov/22224497
https://pubmed.ncbi.nlm.nih.gov/22224497
Autor:
Michael Petraschka, Klaus-Dieter Wernecke, Claudia Spies, Stefanie Zenker, A. Reißhauer, Tanja Newie, Kai Hermanns, M. Schenk
Publikováno v:
The journal of pain. 7(6)
According to Prochaska’s transtheoretical model, the Freiburg Questionnaire stages of chronic pain management (FQ-STAPM) were used to classify chronic back patients into 4 distinct motivational stages. The FQ-STAMP was completed by 163 chronic back
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab14259e0d2a12d49a2f049b2ff5a203
https://pubmed.ncbi.nlm.nih.gov/16750798
https://pubmed.ncbi.nlm.nih.gov/16750798
Publikováno v:
Anesthesia and analgesia. 76(5)
A prospective, randomized, double-blind study investigating the efficacy of intranasal meperidine as compared with intravenous (i.v.) administration for postoperative pain relief is described. The study was limited to the initial titration of pain re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674393339cd5c548bf3e6d2a2b68b8c5
https://pubmed.ncbi.nlm.nih.gov/8484506
https://pubmed.ncbi.nlm.nih.gov/8484506